Philip Scheltens

PROF.DR., (Principal Investigator)

If you made any changes in Pure these will be visible here soon.

Research Output 1999 2020


Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease (Alzheimer's Research and Therapy (2017) 9 (95) DOI: 10.1186/s13195-017-0318-y)

Ostrowitzki, S., Lasser, R. A., Dorflinger, E., Scheltens, P., Barkhof, F., Nikolcheva, T., Ashford, E., Retout, S., Hofmann, C., Delmar, P., Klein, G., Andjelkovic, M., Dubois, B., Boada, M., Blennow, K., Santarelli, L. & Fontoura, P., 2018, In : Alzheimer's Research and Therapy. 10, 1, 99.

Research output: Contribution to journalErratumAcademicpeer-review

Open Access